Institutional-grade stock research. No noise.
Monthly reports, archetype-calibrated. Bear case first, fair value as a range, confidence as a number. No paid coverage, no soft research, no hype.
Five testable promises
Fair value as a range, with a confidence number
Every report publishes a fair-value low / mid / high band rather than a single point estimate, paired with a 0 to 100 confidence score that reflects model agreement and data quality. A wide range with low confidence is information; a single number masquerading as truth is not.
Bear case before bull case
The risk section runs first, in full, with named kill scenarios and quantified downside targets. Optimistic narrative is allowed only after the thesis has been argued against on its own terms. This ordering is structural, not editorial.
Archetype-aware models
A hyper-growth software business and a deep cyclical commodity producer should not be valued the same way. Each ticker is classified into one of nine archetypes, and that classification calibrates discount rates, terminal growth, deceleration curves, terminal multiples, and which valuation models apply.
A scorecard with explicit weights
Every report carries a quantified investment scorecard whose category weights are published, not hidden. Disagreeing with the verdict is fine; disagreeing without seeing the math is what most retail research forces you into.
Quantified stress tests, every report
Five named stress scenarios with dollar-impact estimates run on every covered ticker. Sensitivity grids on cost of equity and terminal growth ship in every report so the durability of the fair-value range is explicit, not implied.
What this is not
Not a signal service, not a copy-trading app, not a paywalled-newsletter cult of personality, not a screener with prose laid on top. The output is a reasoned investment thesis you can argue with, not a trade you are told to make.
On independence
- Three things. Identical methodology applied to every covered ticker so verdicts do not vary by analyst convenience. No banking, no inventory, no soft-dollar arrangements with covered names. Free monthly research on every ticker rather than gated coverage of a curated subset.
- Yes. We do not take payment from covered companies, do not run sponsored content, and do not soften coverage on names that drive subscriber acquisition. Editorial guidelines, the correction policy, and the personal-trading policy for analysts are public.
- Fair value is a probability-weighted composite reconciled across multiple independent valuation lenses, with explicit confidence and a published range. We are wrong sometimes and the range communicates that honestly. The track record of bear-case calls is a more telling signal than the percentage of bull calls that worked out, because the bear case is the harder and rarer call to make.
- No. We publish independent educational research. We are not a broker-dealer, registered investment adviser, or fiduciary. Nothing on this site is personalized investment advice. See the Terms of Service for full regulatory framing.